← Search

Data · dataset · 2025

Quizartinib

Listed in Virginia Open Data Portal

Description

VANFLYTA (quizartinib) is an oral prescription tablet developed by Daiichi Sankyo Inc. for treating certain blood cancers. It works as a kinase inhibitor targeting FLT3 mutations, available in 17.7 mg and 26.5 mg strengths. This information was generated using AI and is provided for informational and research purposes only. --- ### 🔗 Related Datasets - Quizartinib — *HealthData.Gov* - Larotrectinib — *HealthData.Gov* ---

Links

Where it is published

Documentation and papers

Catalogue records · 1

Topics

From keywords
Medicine & Health
Provenance · 1 source records, 6 field assertions
SourceKeyLast seenRaw
Virginia Open Data Portal02b9bbee-4d5e-471b-945c-e4400e985fb22 h agoJSON v1
FieldAssertionExtractorEvidence
concepts[field].local:field:medicine-healthmapping · data virginia govconnector:data_virginia_gov@1.0.0
created_datesource · data virginia govconnector:data_virginia_gov@1.0.0
descriptionsource · data virginia govconnector:data_virginia_gov@1.0.0/notes
publication_datesource · data virginia govconnector:data_virginia_gov@1.0.0
titlesource · data virginia govconnector:data_virginia_gov@1.0.0/title
updated_datesource · data virginia govconnector:data_virginia_gov@1.0.0